Clinical Updates

GlaxoSmithKline Plc’s (GSK.L) top-selling lung drug Advair looks “very sustainable” given the difficulties facing generic companies hoping to making… »   

The pharmaceutical industry’s buying spree will continue and investors may see more big deals as drugmakers seek ways to stave… »   

Nine major pharmaceutical companies have agreed to pool data on drug trials with academic institutions in an effort to improve… »   

Experiments with an artificial stomach suggest that a popular lemon-lime soft drink could play an unexpected role in improving the… »   

The use of statins among a group of postmenopausal women did not reduce the risk for colorectal cancer, according to… »   

Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain,… »   

A closely watched experimental drug for rheumatoid arthritis being developed by Pfizer Inc significantly reduced symptoms and improved physical function,… »   

A new study suggests joint complaints attributed to aromatase inhibitors (AI), popular breast cancer drugs, are not associated with inflammatory… »   

Using high doses of Novo Nordisk’s anti-clotting medicine to treat dangerous bleeding in non-hemophiliacs may raise the risk of heart… »   

Spending more on drugs does not always translate into healthier patients, U.S. researchers reported on Wednesday.

And in a second… »   

Nanoparticles could help smuggle drugs into the gut, according to a study published this month in the International Journal of… »   

A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple… »   

David Henry discusses a recent research article in PLoS Medicine that suggests that relationships between doctors and drug companies are… »   

In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less… »   

An initiative by the U. S. technology company Pitney Bowes to make medications of proven value less expensive for their… »